Analysed CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) News Sources
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
08-07-2026
yahoo.com
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
11-07-2026
marketbeat.com
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
13-07-2026
fool.com
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
14-07-2026
fool.com
What is the current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is $83.52.
CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is $-0.11.
CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is -0.1315%.
What is the most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The most recent sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is .
SEC-8K** Filing Available For CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.